TABLE 2.
Demographic characteristics, clinical diagnoses, HBeAg/anti-HBe status, and genotypes of HBV for the HCC and control groups
| Parameter (unit) | Valuea for the indicated group and HBV genotype (n)
|
|||||
|---|---|---|---|---|---|---|
| HCC (100)
|
Non-HCC (control) (100)
|
|||||
| B (37) | Ce (16) | Cs (47) | B (51) | Ce (10) | Cs (39) | |
| Age (yr) | 51 ± 14 | 54 ± 14 | 50 ± 11 | 52 ± 13 | 48 ± 10 | 47 ± 13 |
| Males | 35 (95) | 13 (81) | 39 (83) | 42 (82) | 6 (60) | 25 (64) |
| Hemoglobin (g/dl) | 12.8 ± 1.6 | 12.8 ± 1.8 | 13.0 ± 2.7 | 14.9 ± 1.0 | 14.0 ± 2.0 | 15.0 ± 1.2 |
| White cells (109/liter) | 7.7 ± 3.2 | 6.3 ± 3.4 | 6.6 ± 2.6 | 6.5 ± 2.0 | 6.0 ± 2.0 | 7.0 ± 2.6 |
| Platelet (109/liter) | 202 ± 117 | 201 ± 128 | 204 ± 96 | 166 ± 60 | 153 ± 68 | 163 ± 60 |
| International normalized ratio | 1.2 ± 0.1 | 1.2 ± 0.1 | 1.2 ± 0.1 | 1.1 ± 0.1 | 1.1 ± 0.2 | 1.0 ± 0.1 |
| Creatinine (mmol/liter) | 89 ± 23 | 92 ± 17 | 91 ± 20 | 89 ± 20 | 77 ± 17 | 82 ± 18 |
| Albumin (g/liter) | 33 ± 6 | 32 ± 4 | 33 ± 5 | 38 ± 4 | 37 ± 4 | 38 ± 5 |
| Alanine transaminase (IU/liter) | 103 ± 90 | 82 ± 54 | 101 ± 102 | 94 ± 36 | 81 ± 21 | 98 ± 49 |
| Alkaline phosphatase (IU/liter) | 227 ± 124 | 239 ± 154 | 212 ± 145 | 94 ± 36 | 81 ± 21 | 98 ± 49 |
| Bilirubin (μmol/liter) | 32 ± 58 | 30 ± 23 | 27 ± 48 | 10 ± 7 | 12 ± 9 | 12 ± 13 |
| Liver cirrhosis present | 24 (65) | 14 (88) | 29 (62) | 6 (11) | 2 (20) | 6 (15) |
| Anti-HCV present | 0 | 0 | 1 | 0 | 0 | 0 |
a
Continuous variables are expressed as means ± standard deviations. Categorical variables are expressed as number (percentage).